Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVT 302 for Smoking Cessation
NCT00738595Phase 2Completed
- Sponsor
- Evotec SE
- Start
- Aug 2008
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sembragiline in Tobacco Use Disorder (TUD), sponsored by Evotec SE. Started Aug 2008; status: completed.
02
Drugs
sembragiline
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00738595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00738595.